Novo Nordisk just introduced a GLP-1 pill, but the company makes more than just weight-loss drugs.

Pfizer is expected to post fourth-quarter adjusted earnings of 57 cents a share on revenue of $16.85 billion, according to analysts polled by FactSet. That compares with adjusted earnings of 63 cents ...

The Morning Bull - US Market Morning Update Monday, Feb, 2 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 0.7% and Nasdaq 100 futures off just over 1%, ...

Analysts expect the New York-based company to report quarterly earnings at 57 cents per share, down from 63 cents per share ...

Dividend investors are likely to find the stock's 6.7% yield attractive. That yield is the result of a 100% dividend payout ratio -- meaning the company devotes all its profit to the payments -- so ...

PFE heads into Q4 earnings with strong oncology and Vyndaqel demand, but IRA headwinds, COVID declines and falling estimates ...

Pfizer may look cheap with a ~7% yield, but tight free cash flow, patent cliffs, and limited growth raise downside risk. Read ...

If you like dividend stocks, here's a high yielder, a Dividend King, and a turnaround story to consider as January comes to a ...

Shares of Pfizer Inc. PFE shed 2.42% to $25.86 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.02% to ...

As of Wednesday, January 28, Relay Therapeutics, Inc.’s RLAY share price has dipped by 5.18%, which has investors questioning if this is right time to buy.

Pfizer Inc. has a rare 3-year tariff exemption and margin defense amid global price parity risks. Click here to read an ...

The Dow Industrials climbed more than 500 points Monday, as traders managed to look past declines in gold, silver and bitcoin.